Jed Hubbs, PhD, CEO
Jed has over 10 years of drug discovery experience with a focus on CNS therapeutics. He served as Head of Medicinal Chemistry at Satori Pharmaceuticals and was previously at Merck. He has experience managing complex discovery projects with hybrid internal/external teams and building infrastructure.
Matthew Toczko, PhD, COO
Matthew is a an expert in early-phase Chemistry, Manufacturing and Controls (CMC) with more than 14 years in the CMC sector. He has successfully managed multifarious projects from diverse therapeutic areas and is skilled leading both line and matrix teams.